CClinicalTrials.gg
CompletedNCT00302055Updated Dec 1, 2016Results posted

Feasibility of a Partnered Approach to Prevent Diabetes

An interventional study of Clinical referral to diabetes prevention lifestyle and Clinical referral to group diabetes prevention lifestyle in Pre-diabetic State, Overweight and Obesity, sponsored by Northwestern University. Completed at 2 sites in United States. Open to participants aged 25 Years and older. Per ClinicalTrials.gov, last updated 2016-12-01.

Sponsored by Northwestern University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
25 Years and older
Sex
All
01

Study summary

The Diabetes Prevention Program (DPP) demonstrated that an intensive lifestyle intervention resulting in modest weight loss and increased physical activity can delay or prevent the development of type 2 diabetes in those at increase risk for the disease. The lifestyle program used, however, was not designed for delivery on a public health scale. Successful DPP translation will require a sustainable partnership between a health care system and an established community organization committed to community health and experienced in implementing sustainable health and wellness programs. We have been collaborating with local health system and community administrators for over a year to design a 'real-world' clinic-based screening model to identify and refer high-risk patients for a group-based adaptation of the DPP lifestyle intervention in community facilities. We have designed this study to develop preliminary data about the feasibility and yield of clinic-based screening and referral, as well as the effectiveness of the adapted lifestyle intervention. This pilot study seeks to: 1) evaluate the feasibility of a strategy to implement American Diabetes Association (ADA) recommendations for clinic-based diabetes-risk testing and to refer high-risk patients for a community-based lifestyle intervention; 2) compare two strategies to enhance community-based program participation by referred patients; 3) demonstrate the capability of community facilities to schedule and enroll referred clinic patients at high-risk for diabetes and to deliver a modified, group-based DPP lifestyle intervention consistently; and 4) compare levels of weight loss and physical activity achieved by referred clinic patients with pre-diabetes who participate in a free-of-charge, group-based DPP lifestyle intervention at community facilities compared to a free-of-charge, traditional, one-on-one DPP lifestyle intervention at a DPP research site. Addressing these issues now will enable us to evaluate this partnered DPP translation model with a larger, more robust future study that will involve referral by multiple primary care clinics, program delivery at more community sites, and a 3-year follow-up period.

02

Conditions studied

  • Pre-diabetic State
  • Overweight
  • Obesity
03

In context

Overweight

3,670 studies on the registry are indexed under Overweight; 849 are open to participants now.

This study's enrollment of 72 is close to the median of 73 across 3,175 interventional studies indexed under Overweight.

Browse Overweight studies →

Lead sponsor

Northwestern University is the lead sponsor of 1,398 studies on the registry; 201 are open to participants now.

Of its 102 completed or terminated interventional studies of FDA-regulated products, 73 (72%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

25 years of age or older Body-mass index of >= 24 kg/m2

  1. or more additional risk factors if age is \<45

    • Parent or sibling with diabetes
    • Minority race or ethnicity
    • History of gestational diabetes
    • Delivery of infant >= 9 lbs.
    • History of high blood pressure
    • History of dyslipidemia
    • Polycystic Ovarian Syndrome
    • History of vascular disease Fasting Capillary Glucose 95 - 125 mg/dl 2-hour Post-challenge Capillary Glucose 140 - 199 mg/dl

Exclusion criteria

Exclusion Criteria:

Diseases that could limit lifespan or increase risk with a lifestyle intervention - Cancer diagnosed in the past 5 years

  • Significant Cardiovascular Disease
  • A "Yes" response to any item on the modified Physical Activity Readiness Questionnaire
  • Uncontrolled hypertension: systolic blood pressure >180 mmHg or diastolic blood pressure >105 mmHg
  • Heart attack, stroke, or transient ischemic attack within 6 months
  • Chest pain or unexplained dizziness or fainting with physical exertion
  • Chronic obstructive pulmonary disease or asthma needing home oxygen
  • Other chronic disease or condition, such as advanced arthritis, that could limit ability to become physically active or limit life span to \<5 years
  • Any other known reason for not participating in regular physical activity

Exclusions related to metabolism - Past anti-diabetes medication use, except during gestational diabetes

  • Use of a medications known to produce hyperglycemia
  • Known disease leading to abnormal glucose metabolism

Exclusions for conditions / behaviors likely to affect study conduct

  • Unable or unwilling to provide informed consent
  • Unable to communicate with the pertinent clinic staff
  • Unable to read written English or Spanish
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
72 participants (actual)

Study arms

  • Active comparator
    one-on-one lifestyle

    Clinical referral to diabetes prevention lifestyle intervention at School of Medicine campus

    Behavioral: Clinical referral to diabetes prevention lifestyle

  • Experimental
    group-based community lifestyle

    Clinical referral to group diabetes prevention lifestyle intervention program in community

    Behavioral: Clinical referral to group diabetes prevention lifestyle

Interventions

  • BehavioralClinical referral to diabetes prevention lifestyle

    16 one-hour lifestyle program sessions (diet and physical activity skill building and problem solving) delivered about once weekly over 20-24 weeks, followed by monthly lifestyle maintenance sessions

  • BehavioralClinical referral to group diabetes prevention lifestyle

    16 one-hour lifestyle program sessions (diet and physical activity skill building and problem solving) delivered about once weekly over 20-24 weeks, followed by monthly lifestyle maintenance sessions

06

What researchers measure

Primary outcomes

  1. Weight Loss

    We analyzed repeated outcome measures using longitudinal linear regression with 3 observations per participant (baseline, 6 months, and 12 months)

    Time frame: 12 months

Secondary outcomes

  1. Self Report Physical Activity

    Time frame: 12 months

  2. Rate of Community Program Participation

    Time frame: 6 months

07

Results

Posted Dec 18, 2014

Participant flow

Participant flow — Overall Study
MilestoneOne-on-one LifestyleGroup-based Community Lifestyle
Started2349
Completed1436
Not completed913

Outcome measures

PrimaryWeight Loss

We analyzed repeated outcome measures using longitudinal linear regression with 3 observations per participant (baseline, 6 months, and 12 months)

Time frame:
12 months
Reported as:
Mean · kilograms
Weight Loss
kilogramsOne-on-one LifestyleGroup-based Community Lifestyle
Weight Loss4.37 (3.33 to 5.42)3.23 (2.16 to 4.30)
SecondarySelf Report Physical Activity
Time frame:
12 months

Results for this outcome have not been posted.

SecondaryRate of Community Program Participation
Time frame:
6 months

Results for this outcome have not been posted.

Adverse events

Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
One-on-one Lifestyle—0/23 (0%)0/23 (0%)
Group-based Community Lifestyle—0/49 (0%)0/49 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)One-on-one LifestyleGroup-based Community LifestyleTotal
<=18 years000
Between 18 and 65 years234972
>=65 years000
Age, Continuous
Age, Continuous(years)One-on-one LifestyleGroup-based Community LifestyleTotal
Mean53.0 ± 10.752.8 ± 13.152.9 ± 11.9
Sex: Female, Male
Sex: Female, Male(Participants)One-on-one LifestyleGroup-based Community LifestyleTotal
Female174259
Male6713
Region of Enrollment
Region of Enrollment(participants)One-on-one LifestyleGroup-based Community LifestyleTotal
United States234972
08

Study locations

2 sites
  • IU Medical Group Westside Clinic
    Indianapolis, Indiana 46222, United States
  • IU Medical Group Banta Road Clinic
    Indianapolis, Indiana 46227, United States
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 1, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00302055
Lead sponsor
Northwestern University
Responsible party
Ronald Ackermann (Professor, Northwestern University) — Principal investigator
First posted
Mar 13, 2006
Start date
Mar 2006
Primary completion
Jul 2007
Completion
Jul 2007
Results posted
Dec 18, 2014
Last update
Dec 1, 2016

Study contacts

Ronald T Ackermann, MD, MPH
principal investigator · Northwestern University Feinberg School of Medicine

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion